The GMP facility has been specifically designed to deliver the next generation of anticancer blockbuster ADC drugs for patients globally …
New Delhi, May 20, 2018: ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience Managers, is to host a…
Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach Wales, April 25, 2018: ADC Biotechnology (ADC Bio), announces that it has secured £1.14…